For millions of people living with long COVID, symptoms like shortness of breath, mental fog, and deep fatigue continue long ...
COVID-19 brought unprecedented public attention to the development, regulation, and timeline for products that prevent deadly infections, potentially heralding an era of vaccine innovation marked by ...
In November 2024, the Data Safety Monitoring Board (DSMB) for the ongoing Phase 2 clinical trial of GEO-CM04S1 as a booster vaccine for patients with CLL conducted an interim data review of the study.
The 2024–2025 formulations of COVID-19 vaccines had an effectiveness rate of 76% at preventing emergency or urgent care visits in children aged 9 months through four years, according to a new report.
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Infants and toddlers faced socio-emotional development ...
The large impact of school closures on children’s mental health may stem from changes in social interaction, disrupted sleep, ...